Page last updated: 2024-11-12

aceglutamide aluminum

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aceglutamide aluminum: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10463869
CHEBI ID31161
MeSH IDM0042963

Synonyms (28)

Synonym
aluminum, pentakis(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytri-
aceglutamide aluminum [usan:jan]
aceglutamide aluminum
pentakis(n(2)-acetyl-l-glutaminato)tetrahydroxytrialuminum
kw 110
glumal
kw-110
aceglutamide aluminium
aluminum aceglutamide
pentakis(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytrialuminum
pentakis (n(sup 2)-acetyl-l-glutaminato)tetrahydroxytrialuminum
12607-92-0
glumal (tn)
D01660
aceglutamide aluminum (jan/usan)
r7qtg0pmpx ,
unii-r7qtg0pmpx
aceglutamide aluminum [usan]
(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytrialuminium
(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytrialuminum
aceglutamide aluminum [jan]
aceglutamide aluminium [who-dd]
aluminium, pentakis(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytri-
pentakis (n(sup 2)-acetyl-l-glutaminato)tetrahydroxytrialuminium
aceglutamide aluminium [mart.]
CHEBI:31161
trialuminum;(2s)-2-acetamido-5-amino-5-oxopentanoate;tetrahydroxide
Q27287918
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glutamine derivativeA glutamic acid derivative resulting from reaction of glutamine acid at the amino group, the carboxy group, or the side-chain carboxamide, or from the replacement of any hydrogen by a heteroatom. The definition normally excludes peptides containing glutamine residues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]